24 LIfesciences trend

  G lobal pipette controllers market is entering a phase of sustained expansion, driven by rising laboratory automation, precision-based research, and stricter compliance protocols across pharmaceutical and biotechnology workflows. Valued at USD 209 million in 2024 , the market is projected to reach USD 294 million by 2031 , registering a CAGR of 5.1% during the forecast period. For full insights, downloadable data tables, and competitive intelligence, visit the Pipette Controllers Market Intelligence Page on 24LifeSciences : https://www.24lifesciences.com/pipette-contollers-market-market-6022 Emerging Healthcare Trends Shaping Market Growth The modern laboratory ecosystem is undergoing rapid transformation as precision medicine, genomics, and digital science converge. Increasing uptake of electronic pipette controllers aligns with broader industry priorities involving laboratory automation and high-throughput liquid handling. Innovation-led laboratory ecosystems — ...

  G lobal asthma care equipment market is entering a period of robust expansion driven by rising asthma prevalence, accelerating use of digital respiratory tools, and growing emphasis on patient self-management. Valued at USD 7.89 billion in 2024 , the market is projected to advance to USD 8.4 billion in 2025 and ultimately reach USD 12.33 billion by 2032 , reflecting a steady CAGR of 5.8% . The shift toward personalized and home-based asthma management continues to reshape global demand patterns across healthcare ecosystems. Access the complete report with in-depth data, forecasts, and competitive insights at 24LifeSciences https://www.24lifesciences.com/asthma-care-equipment-market-9437 Competitive Landscape: Companies Advancing Global Asthma Innovation A core group of innovators is accelerating progress in asthma management through strategic investments and next-generation product development: Respiri – Pioneering digital wheeze detection and remote respirato...

  G lobal brain tumor diagnosis and therapeutics market is undergoing accelerated transformation driven by technological breakthroughs in imaging, molecular diagnostics, and personalized treatment approaches. Valued at USD 2.66 billion in 2024 , the market is projected to reach USD 2.95 billion in 2025 and expand to USD 5.30 billion by 2032 , exhibiting an impressive CAGR of 10.6% . Rising disease awareness, growing investments in advanced neurosurgical facilities, and rapid adoption of integrated multimodal therapies are reshaping the landscape of neuro-oncology worldwide. Access the full report with detailed insights, market forecasts, and competitive analysis at 24LifeSciences. https://www.24lifesciences.com/brain-tumor-diagnosis-and-therapeutics-market-9371 Segment Insights & Regional Overview By Type MRI remains the dominant diagnostic modality due to its superior soft-tissue contrast, high-resolution imaging capabilities, and non-invasive nature. Molecular te...